US FDA Staff Question Pfizer Inc. (JOBS) Lung Drug Data

Reuters -- U.S. reviewers will ask an advisory panel about statistical issues and safety concerns as they weigh a proposed new claim for a lung drug sold by Pfizer Inc (PFE.N) and Boehringer Ingelheim, documents released on Tuesday said.